Skip to main content

Find Clinical Trials

Home
Conditions
B Cell Leukemia

Clinical trial condition

B Cell Leukemia

Explore clinical trials studying B Cell Leukemia. Study availability and eligibility vary by location and protocol.

6 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

B Cell Leukemia trial results

Not Yet Recruiting

Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL

NCT05779930

Conditions: Acute Lymphoblastic Leukemia With Failed Remission, Acute Lymphoblastic Leukemia, in Relapse, B Cell Leukemia, +22 more
Locations: Nationwide Children's Hospital Columbus, Ohio, United States

View Trial Details

Completed

CD19-CAR-T2 Cells for CD19 Positive B Cell Malignancies

NCT04605666

Conditions: B Cell Leukemia, B Cell Lymphoma, Hematologic Diseases, +13 more
Locations: Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Completed

Study of the Prognostic Role of Gene Polymorphism in the Development of B-cell Leukemias and Lymphomas in Children of Kazakh Nationality

NCT05095155

Conditions: B Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Scientific Center of Pediatrics and Pediatric Surgery Almaty, Kazakhstan

View Trial Details

Completed

Phase I/IIA Study of CART19 Cells for Patients With Chemotherapy Resistant or Refractory CD19+ Leukemia and Lymphoma

NCT01626495

Conditions: B Cell Leukemia, B Cell Lymphoma, Hematologic Diseases, +13 more
Locations: CHOP - http://www.chop.edu/service/oncology/pediatric-cancer-research/cart-19-trial.html Philadelphia, Pennsylvania, United States

View Trial Details

Completed

CD19-targeting 3rd Generation CAR T Cells for Refractory B Cell Malignancy - a Phase I/IIa Trial.

NCT02132624

Conditions: B Cell Leukemia, B Cell Lymphoma, Hematologic Diseases, +13 more
Locations: Uppsala University Hospital, Dept of Oncology Uppsala, Sweden

View Trial Details

Active, Not Recruiting

A Pediatric Trial of Genetically Modified Autologous T Cells Directed Against CD19 for Relapsed CD19+ Acute Lymphoblastic Leukemia

NCT01683279

Conditions: B Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Seattle Children's Hospital Seattle, Washington, United States

View Trial Details